AMPHETAMINE\DEXTROAMPHETAMINE: 1,926 Adverse Event Reports & Safety Profile
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
1,926
Total FAERS Reports
218 (11.3%)
Deaths Reported
183
Hospitalizations
1,926
As Primary/Secondary Suspect
37
Life-Threatening
22
Disabilities
Active Ingredient: AMPHETAMINE SULFATE\DEXTROAMPHETAMINE ·
First Report: 20030420 · Latest Report: 20250827
What Are the Most Common AMPHETAMINE\DEXTROAMPHETAMINE Side Effects?
#1 Most Reported
Drug ineffective
803 reports (41.7%)
#2 Most Reported
Product substitution issue
216 reports (11.2%)
#3 Most Reported
Headache
176 reports (9.1%)
All AMPHETAMINE\DEXTROAMPHETAMINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 803 | 41.7% | 0 | 6 |
| Product substitution issue | 216 | 11.2% | 0 | 2 |
| Headache | 176 | 9.1% | 1 | 1 |
| Disturbance in attention | 158 | 8.2% | 0 | 2 |
| Fatigue | 146 | 7.6% | 0 | 5 |
| Completed suicide | 144 | 7.5% | 144 | 43 |
| Feeling abnormal | 125 | 6.5% | 0 | 3 |
| Anxiety | 104 | 5.4% | 0 | 8 |
| Somnolence | 104 | 5.4% | 0 | 2 |
| Nausea | 88 | 4.6% | 0 | 2 |
| Product quality issue | 73 | 3.8% | 0 | 1 |
| Depression | 65 | 3.4% | 0 | 6 |
| Insomnia | 61 | 3.2% | 0 | 1 |
| Irritability | 60 | 3.1% | 0 | 5 |
| Toxicity to various agents | 58 | 3.0% | 48 | 21 |
| Malaise | 54 | 2.8% | 0 | 2 |
| Product physical issue | 54 | 2.8% | 0 | 1 |
| Dizziness | 50 | 2.6% | 0 | 3 |
| Adverse event | 47 | 2.4% | 0 | 0 |
| Drug effect decreased | 46 | 2.4% | 0 | 1 |
Who Reports AMPHETAMINE\DEXTROAMPHETAMINE Side Effects? Age & Gender Data
Gender: 64.4% female, 35.6% male. Average age: 37.4 years. Most reports from: US. View detailed demographics →
Is AMPHETAMINE\DEXTROAMPHETAMINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2003 | 1 | 0 | 0 |
| 2004 | 1 | 0 | 0 |
| 2005 | 1 | 0 | 0 |
| 2009 | 1 | 0 | 0 |
| 2010 | 1 | 0 | 1 |
| 2012 | 3 | 1 | 0 |
| 2013 | 21 | 13 | 0 |
| 2014 | 41 | 4 | 4 |
| 2015 | 72 | 8 | 4 |
| 2016 | 84 | 3 | 2 |
| 2017 | 47 | 8 | 3 |
| 2018 | 45 | 1 | 2 |
| 2019 | 42 | 3 | 4 |
| 2020 | 36 | 3 | 3 |
| 2021 | 37 | 6 | 1 |
| 2022 | 60 | 4 | 6 |
| 2023 | 43 | 12 | 2 |
| 2024 | 19 | 0 | 1 |
| 2025 | 24 | 0 | 0 |
What Is AMPHETAMINE\DEXTROAMPHETAMINE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 413 |
| Attention deficit/hyperactivity disorder | 407 |
| Attention deficit hyperactivity disorder | 229 |
| Narcolepsy | 35 |
| Depression | 26 |
| Suicide attempt | 24 |
| Fatigue | 12 |
| Disturbance in attention | 9 |
| Hypersomnia | 6 |
| Major depression | 5 |
AMPHETAMINE\DEXTROAMPHETAMINE vs Alternatives: Which Is Safer?
AMPHETAMINE\DEXTROAMPHETAMINE vs AMPHOTERICIN B
AMPHETAMINE\DEXTROAMPHETAMINE vs AMPHOTERICIN B\DIMYRISTOYLPHOSPHATIDYLCHOLINE, DL-\DIMYRISTOYLPHOSPHATIDYLGLYCEROL, DL-
AMPHETAMINE\DEXTROAMPHETAMINE vs AMPICILLIN
AMPHETAMINE\DEXTROAMPHETAMINE vs AMPICILLIN\SULBACTAM
AMPHETAMINE\DEXTROAMPHETAMINE vs AMPRENAVIR
AMPHETAMINE\DEXTROAMPHETAMINE vs AMPYRA
AMPHETAMINE\DEXTROAMPHETAMINE vs AMRUBICIN
AMPHETAMINE\DEXTROAMPHETAMINE vs AMSACRINE
AMPHETAMINE\DEXTROAMPHETAMINE vs ANAGRELIDE
AMPHETAMINE\DEXTROAMPHETAMINE vs ANAKINRA
Official FDA Label for AMPHETAMINE\DEXTROAMPHETAMINE
Official prescribing information from the FDA-approved drug label.